

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 5.44466675 |
| 2 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.37135499 |
| 3 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.81335072 |
| 4 | protein deneddylation (GO:0000338) | 4.56792643 |
| 5 | rRNA modification (GO:0000154) | 4.25701414 |
| 6 | proteasome assembly (GO:0043248) | 4.17421963 |
| 7 | protein localization to kinetochore (GO:0034501) | 4.12194649 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11960015 |
| 9 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.08968270 |
| 10 | NADH dehydrogenase complex assembly (GO:0010257) | 4.08968270 |
| 11 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.08968270 |
| 12 | cullin deneddylation (GO:0010388) | 4.07749917 |
| 13 | protein complex biogenesis (GO:0070271) | 4.01921146 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.94749100 |
| 15 | ATP synthesis coupled proton transport (GO:0015986) | 3.94749100 |
| 16 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.91489556 |
| 17 | kinetochore organization (GO:0051383) | 3.88868907 |
| 18 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.87799670 |
| 19 | mitotic metaphase plate congression (GO:0007080) | 3.86557871 |
| 20 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.85577506 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 3.79434473 |
| 22 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.78167907 |
| 23 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.76829086 |
| 24 | meiotic chromosome segregation (GO:0045132) | 3.75437224 |
| 25 | metaphase plate congression (GO:0051310) | 3.73393681 |
| 26 | respiratory chain complex IV assembly (GO:0008535) | 3.67556635 |
| 27 | rRNA methylation (GO:0031167) | 3.65216152 |
| 28 | mitotic sister chromatid segregation (GO:0000070) | 3.63672366 |
| 29 | transcription from mitochondrial promoter (GO:0006390) | 3.61832994 |
| 30 | establishment of chromosome localization (GO:0051303) | 3.58910175 |
| 31 | protein-cofactor linkage (GO:0018065) | 3.55193660 |
| 32 | DNA deamination (GO:0045006) | 3.54712102 |
| 33 | CENP-A containing nucleosome assembly (GO:0034080) | 3.50273816 |
| 34 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.50201923 |
| 35 | sister chromatid segregation (GO:0000819) | 3.46844599 |
| 36 | protein localization to chromosome, centromeric region (GO:0071459) | 3.46130244 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.42259471 |
| 38 | kinetochore assembly (GO:0051382) | 3.37641745 |
| 39 | platelet dense granule organization (GO:0060155) | 3.37598853 |
| 40 | chromatin remodeling at centromere (GO:0031055) | 3.37510682 |
| 41 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.35961941 |
| 42 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.34587509 |
| 43 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.34478191 |
| 44 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.32288805 |
| 45 | synapsis (GO:0007129) | 3.31281507 |
| 46 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.28917108 |
| 47 | termination of RNA polymerase III transcription (GO:0006386) | 3.26888325 |
| 48 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.26888325 |
| 49 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.25231987 |
| 50 | DNA unwinding involved in DNA replication (GO:0006268) | 3.24254893 |
| 51 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.24031369 |
| 52 | respiratory electron transport chain (GO:0022904) | 3.22627476 |
| 53 | electron transport chain (GO:0022900) | 3.20665843 |
| 54 | mitotic recombination (GO:0006312) | 3.19799042 |
| 55 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19391586 |
| 56 | maturation of 5.8S rRNA (GO:0000460) | 3.18326536 |
| 57 | mitotic chromosome condensation (GO:0007076) | 3.18273592 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.16938015 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.16938015 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.16938015 |
| 61 | piRNA metabolic process (GO:0034587) | 3.15806273 |
| 62 | DNA strand elongation (GO:0022616) | 3.15062873 |
| 63 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.12602527 |
| 64 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.12602527 |
| 65 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.12390017 |
| 66 | negative regulation of ligase activity (GO:0051352) | 3.12390017 |
| 67 | telomere maintenance via recombination (GO:0000722) | 3.09927906 |
| 68 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.09917928 |
| 69 | regulation of helicase activity (GO:0051095) | 3.09800141 |
| 70 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.09300815 |
| 71 | DNA replication-independent nucleosome organization (GO:0034724) | 3.09300815 |
| 72 | regulation of meiosis I (GO:0060631) | 3.07310271 |
| 73 | DNA replication initiation (GO:0006270) | 3.06220912 |
| 74 | mitotic nuclear envelope disassembly (GO:0007077) | 3.05932214 |
| 75 | protein targeting to mitochondrion (GO:0006626) | 3.05821519 |
| 76 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.04148769 |
| 77 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.04148769 |
| 78 | protein localization to chromosome (GO:0034502) | 3.01808721 |
| 79 | nuclear pore organization (GO:0006999) | 3.00349545 |
| 80 | spindle checkpoint (GO:0031577) | 3.00064443 |
| 81 | DNA damage response, detection of DNA damage (GO:0042769) | 2.99421112 |
| 82 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.98618688 |
| 83 | regulation of spindle organization (GO:0090224) | 2.98102519 |
| 84 | organelle disassembly (GO:1903008) | 2.97902093 |
| 85 | ribosomal small subunit assembly (GO:0000028) | 2.96478248 |
| 86 | pseudouridine synthesis (GO:0001522) | 2.96276780 |
| 87 | cytochrome complex assembly (GO:0017004) | 2.95781624 |
| 88 | meiosis I (GO:0007127) | 2.94458503 |
| 89 | mitotic sister chromatid cohesion (GO:0007064) | 2.94175971 |
| 90 | nuclear pore complex assembly (GO:0051292) | 2.93420224 |
| 91 | male meiosis I (GO:0007141) | 2.93352290 |
| 92 | DNA double-strand break processing (GO:0000729) | 2.93112834 |
| 93 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.92757967 |
| 94 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.92467452 |
| 95 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.92467452 |
| 96 | protein localization to mitochondrion (GO:0070585) | 2.90057547 |
| 97 | cotranslational protein targeting to membrane (GO:0006613) | 2.89912405 |
| 98 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.89725496 |
| 99 | establishment of protein localization to mitochondrion (GO:0072655) | 2.88842529 |
| 100 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.88233768 |
| 101 | cellular component biogenesis (GO:0044085) | 2.88127124 |
| 102 | chromosome segregation (GO:0007059) | 2.86430514 |
| 103 | regulation of mitotic spindle organization (GO:0060236) | 2.85484413 |
| 104 | positive regulation of ligase activity (GO:0051351) | 2.85103009 |
| 105 | mitochondrial RNA metabolic process (GO:0000959) | 2.84529035 |
| 106 | translation (GO:0006412) | 2.84451505 |
| 107 | translational termination (GO:0006415) | 2.84173432 |
| 108 | establishment of integrated proviral latency (GO:0075713) | 2.83748139 |
| 109 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.83162004 |
| 110 | termination of RNA polymerase I transcription (GO:0006363) | 2.82421776 |
| 111 | protein targeting to ER (GO:0045047) | 2.80590698 |
| 112 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.79857412 |
| 113 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.79857412 |
| 114 | telomere maintenance via telomere lengthening (GO:0010833) | 2.79217918 |
| 115 | viral transcription (GO:0019083) | 2.78999203 |
| 116 | spindle assembly checkpoint (GO:0071173) | 2.77771625 |
| 117 | DNA ligation (GO:0006266) | 2.75668204 |
| 118 | positive regulation of mitochondrial fission (GO:0090141) | 2.75404576 |
| 119 | base-excision repair, AP site formation (GO:0006285) | 2.74580330 |
| 120 | nuclear envelope disassembly (GO:0051081) | 2.74248463 |
| 121 | membrane disassembly (GO:0030397) | 2.74248463 |
| 122 | regulation of DNA endoreduplication (GO:0032875) | 2.73603826 |
| 123 | mitotic spindle checkpoint (GO:0071174) | 2.72703649 |
| 124 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.72346308 |
| 125 | tRNA processing (GO:0008033) | 2.72178219 |
| 126 | DNA replication checkpoint (GO:0000076) | 2.71407883 |
| 127 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.71052331 |
| 128 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.70812236 |
| 129 | ribonucleoprotein complex disassembly (GO:0032988) | 2.70689947 |
| 130 | histone H2A acetylation (GO:0043968) | 2.70579599 |
| 131 | GDP-mannose metabolic process (GO:0019673) | 2.69888308 |
| 132 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.69427279 |
| 133 | negative regulation of sister chromatid segregation (GO:0033046) | 2.69427279 |
| 134 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.69427279 |
| 135 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.69427279 |
| 136 | histone exchange (GO:0043486) | 2.67823647 |
| 137 | mitotic spindle assembly checkpoint (GO:0007094) | 2.67647824 |
| 138 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.67425348 |
| 139 | protein localization to endoplasmic reticulum (GO:0070972) | 2.67172956 |
| 140 | rRNA processing (GO:0006364) | 2.67011760 |
| 141 | nucleoside transmembrane transport (GO:1901642) | 2.66152255 |
| 142 | mismatch repair (GO:0006298) | 2.65992919 |
| 143 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.65425490 |
| 144 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.64129920 |
| 145 | negative regulation of chromosome segregation (GO:0051985) | 2.62767161 |
| 146 | regulation of chromosome segregation (GO:0051983) | 2.62128029 |
| 147 | regulation of centrosome cycle (GO:0046605) | 2.61652532 |
| 148 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.59094744 |
| 149 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.59094744 |
| 150 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.58459226 |
| 151 | microtubule depolymerization (GO:0007019) | 2.55887662 |
| 152 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.55074136 |
| 153 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.54615087 |
| 154 | histone mRNA metabolic process (GO:0008334) | 2.53781186 |
| 155 | protein K6-linked ubiquitination (GO:0085020) | 2.53532197 |
| 156 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.53202862 |
| 157 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.51136955 |
| 158 | DNA topological change (GO:0006265) | 2.50774987 |
| 159 | regulation of centriole replication (GO:0046599) | 2.50737859 |
| 160 | telomere maintenance (GO:0000723) | 2.50098369 |
| 161 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.49476471 |
| 162 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.49476471 |
| 163 | regulation of sister chromatid segregation (GO:0033045) | 2.49476471 |
| 164 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.49142095 |
| 165 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.48088564 |
| 166 | telomere organization (GO:0032200) | 2.47118672 |
| 167 | RNA-dependent DNA replication (GO:0006278) | 2.44752960 |
| 168 | RNA capping (GO:0036260) | 2.44280068 |
| 169 | 7-methylguanosine RNA capping (GO:0009452) | 2.44280068 |
| 170 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.44130931 |
| 171 | ribosomal large subunit biogenesis (GO:0042273) | 2.42065147 |
| 172 | 7-methylguanosine mRNA capping (GO:0006370) | 2.41304825 |
| 173 | ATP-dependent chromatin remodeling (GO:0043044) | 2.40650665 |
| 174 | chromatin assembly or disassembly (GO:0006333) | 2.39915128 |
| 175 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.37330912 |
| 176 | isotype switching (GO:0045190) | 2.37330912 |
| 177 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.37330912 |
| 178 | pore complex assembly (GO:0046931) | 2.37272618 |
| 179 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.36410479 |
| 180 | positive regulation of chromosome segregation (GO:0051984) | 2.36369036 |
| 181 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.35701022 |
| 182 | mitotic cell cycle (GO:0000278) | 2.34015764 |
| 183 | RNA splicing, via transesterification reactions (GO:0000375) | 2.33056704 |
| 184 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.31580742 |
| 185 | establishment of viral latency (GO:0019043) | 2.31498276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.76870891 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.01203549 |
| 3 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.06807254 |
| 4 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.64911879 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04914175 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.99688038 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.75757606 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.69244982 |
| 9 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68638704 |
| 10 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.63105373 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.55578601 |
| 12 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.52223928 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.45795032 |
| 14 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.45668453 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45129572 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.29416658 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.29346768 |
| 18 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.25018936 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.23357842 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.14937197 |
| 21 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.12690908 |
| 22 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.09023729 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.07005947 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06312463 |
| 25 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.06220330 |
| 26 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.05209449 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.04851850 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.04797169 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02612180 |
| 30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.01412383 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01271143 |
| 32 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.00113151 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98454619 |
| 34 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.98093497 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.97676791 |
| 36 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.93003524 |
| 37 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90041198 |
| 38 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86139583 |
| 39 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.85080001 |
| 40 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.85037340 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.82367689 |
| 42 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.82262016 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75835160 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74156077 |
| 45 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.73283218 |
| 46 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.66337206 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65945496 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.63545181 |
| 49 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59260997 |
| 50 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53446105 |
| 51 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52469463 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.51467747 |
| 53 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.50793352 |
| 54 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.50078637 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46871816 |
| 56 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.46239264 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44310296 |
| 58 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39443515 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39010075 |
| 60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35990087 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.34282542 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31285325 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.31231247 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30241667 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28938274 |
| 66 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.28077756 |
| 67 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.25032709 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22840291 |
| 69 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21023568 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20965771 |
| 71 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20200725 |
| 72 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.16987753 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14812349 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12963951 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12317297 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11679741 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10710395 |
| 78 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09721416 |
| 79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.08789698 |
| 80 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08044456 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06820921 |
| 82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06378422 |
| 83 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05702512 |
| 84 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05684928 |
| 85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04737999 |
| 86 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.04417228 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04138814 |
| 88 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.03766379 |
| 89 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03319307 |
| 90 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02295961 |
| 91 | MYB_26560356_Chip-Seq_TH2_Human | 1.01409159 |
| 92 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.99596735 |
| 93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99527309 |
| 94 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98561803 |
| 95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97113719 |
| 96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97049457 |
| 97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96801691 |
| 98 | MYC_22102868_ChIP-Seq_BL_Human | 0.96795864 |
| 99 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96685629 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96305954 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95360642 |
| 102 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.94546172 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93817370 |
| 104 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.93317421 |
| 105 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.92466318 |
| 106 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92397577 |
| 107 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90394357 |
| 108 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89017476 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88606794 |
| 110 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88264191 |
| 111 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.88224390 |
| 112 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88153923 |
| 113 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86628057 |
| 114 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86497184 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86026490 |
| 116 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.85696512 |
| 117 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.85205107 |
| 118 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.84562961 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.84441252 |
| 120 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.84337423 |
| 121 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.83953338 |
| 122 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.83236839 |
| 123 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82821329 |
| 124 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.80964291 |
| 125 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.80352468 |
| 126 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.79133108 |
| 127 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77599307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.44858903 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.42883105 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 3.20454816 |
| 4 | MP0003077_abnormal_cell_cycle | 2.88204919 |
| 5 | MP0003111_abnormal_nucleus_morphology | 2.87031168 |
| 6 | MP0008057_abnormal_DNA_replication | 2.86311319 |
| 7 | MP0001529_abnormal_vocalization | 2.76739886 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.58164638 |
| 9 | MP0008058_abnormal_DNA_repair | 2.52607922 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.50132364 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.45585044 |
| 12 | MP0004147_increased_porphyrin_level | 2.40663683 |
| 13 | MP0003136_yellow_coat_color | 2.36362823 |
| 14 | MP0003941_abnormal_skin_development | 2.11612914 |
| 15 | MP0003186_abnormal_redox_activity | 2.07152906 |
| 16 | MP0008932_abnormal_embryonic_tissue | 2.04472575 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.03050309 |
| 18 | MP0006035_abnormal_mitochondrial_morpho | 2.02492476 |
| 19 | MP0002102_abnormal_ear_morphology | 1.91627447 |
| 20 | MP0002396_abnormal_hematopoietic_system | 1.89781775 |
| 21 | MP0003880_abnormal_central_pattern | 1.86578962 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.85586925 |
| 23 | MP0001986_abnormal_taste_sensitivity | 1.83939108 |
| 24 | MP0005253_abnormal_eye_physiology | 1.81392319 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 1.79663713 |
| 26 | MP0002938_white_spotting | 1.77477147 |
| 27 | MP0008789_abnormal_olfactory_epithelium | 1.71380071 |
| 28 | MP0002210_abnormal_sex_determination | 1.70379197 |
| 29 | MP0009053_abnormal_anal_canal | 1.69884315 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.67470150 |
| 31 | MP0001929_abnormal_gametogenesis | 1.65003543 |
| 32 | MP0005671_abnormal_response_to | 1.64097953 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.61578528 |
| 34 | MP0003011_delayed_dark_adaptation | 1.57926057 |
| 35 | MP0002751_abnormal_autonomic_nervous | 1.56433512 |
| 36 | MP0000350_abnormal_cell_proliferation | 1.54551617 |
| 37 | MP0002132_abnormal_respiratory_system | 1.54359265 |
| 38 | MP0005171_absent_coat_pigmentation | 1.53040399 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.50332946 |
| 40 | MP0003121_genomic_imprinting | 1.50238346 |
| 41 | MP0008877_abnormal_DNA_methylation | 1.49711315 |
| 42 | MP0003123_paternal_imprinting | 1.49567363 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.48614375 |
| 44 | MP0000566_synostosis | 1.46533921 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.44175926 |
| 46 | MP0009785_altered_susceptibility_to | 1.43929954 |
| 47 | MP0004133_heterotaxia | 1.42184936 |
| 48 | MP0005389_reproductive_system_phenotype | 1.35678364 |
| 49 | MP0002160_abnormal_reproductive_system | 1.35373155 |
| 50 | MP0002398_abnormal_bone_marrow | 1.32795617 |
| 51 | MP0001800_abnormal_humoral_immune | 1.32168370 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.31958697 |
| 53 | MP0000653_abnormal_sex_gland | 1.31276201 |
| 54 | MP0002736_abnormal_nociception_after | 1.30663675 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.30278651 |
| 56 | MP0010307_abnormal_tumor_latency | 1.30134675 |
| 57 | MP0001145_abnormal_male_reproductive | 1.29268304 |
| 58 | MP0000358_abnormal_cell_content/ | 1.28340273 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.27646523 |
| 60 | MP0004142_abnormal_muscle_tone | 1.27582016 |
| 61 | MP0002006_tumorigenesis | 1.27500035 |
| 62 | MP0001293_anophthalmia | 1.27167701 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.26197734 |
| 64 | MP0003195_calcinosis | 1.25600230 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.25445196 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.25329249 |
| 67 | MP0000685_abnormal_immune_system | 1.23285071 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 1.22564483 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.21982431 |
| 70 | MP0000490_abnormal_crypts_of | 1.20928657 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.20178588 |
| 72 | MP0008260_abnormal_autophagy | 1.20076221 |
| 73 | MP0001764_abnormal_homeostasis | 1.19569646 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.19391697 |
| 75 | MP0003937_abnormal_limbs/digits/tail_de | 1.19348082 |
| 76 | MP0002420_abnormal_adaptive_immunity | 1.17616791 |
| 77 | MP0005387_immune_system_phenotype | 1.16669410 |
| 78 | MP0001790_abnormal_immune_system | 1.16669410 |
| 79 | MP0001819_abnormal_immune_cell | 1.16476347 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 1.15557824 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.15242352 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.14842870 |
| 83 | MP0002163_abnormal_gland_morphology | 1.14633516 |
| 84 | MP0002095_abnormal_skin_pigmentation | 1.14423712 |
| 85 | MP0002723_abnormal_immune_serum | 1.12240857 |
| 86 | MP0005391_vision/eye_phenotype | 1.09995607 |
| 87 | MP0002090_abnormal_vision | 1.08838436 |
| 88 | MP0002233_abnormal_nose_morphology | 1.07988973 |
| 89 | MP0005408_hypopigmentation | 1.07053838 |
| 90 | MP0000569_abnormal_digit_pigmentation | 1.06567871 |
| 91 | MP0002019_abnormal_tumor_incidence | 1.06369208 |
| 92 | MP0005174_abnormal_tail_pigmentation | 1.06277519 |
| 93 | MP0000858_altered_metastatic_potential | 1.06096333 |
| 94 | MP0003698_abnormal_male_reproductive | 1.05772384 |
| 95 | MP0000716_abnormal_immune_system | 1.05154711 |
| 96 | MP0002177_abnormal_outer_ear | 1.04642627 |
| 97 | MP0001188_hyperpigmentation | 1.04395267 |
| 98 | MP0000678_abnormal_parathyroid_gland | 1.04374317 |
| 99 | MP0001346_abnormal_lacrimal_gland | 1.03987478 |
| 100 | MP0000647_abnormal_sebaceous_gland | 1.03803389 |
| 101 | MP0002009_preneoplasia | 1.03398569 |
| 102 | MP0001730_embryonic_growth_arrest | 1.02835995 |
| 103 | MP0002249_abnormal_larynx_morphology | 1.02508211 |
| 104 | MP0001324_abnormal_eye_pigmentation | 1.02388013 |
| 105 | MP0002722_abnormal_immune_system | 1.02337099 |
| 106 | MP0005499_abnormal_olfactory_system | 1.02281335 |
| 107 | MP0005394_taste/olfaction_phenotype | 1.02281335 |
| 108 | MP0001853_heart_inflammation | 1.01497952 |
| 109 | MP0003718_maternal_effect | 1.01440017 |
| 110 | MP0000313_abnormal_cell_death | 1.00275874 |
| 111 | MP0003787_abnormal_imprinting | 1.00188657 |
| 112 | MP0002085_abnormal_embryonic_tissue | 0.99045587 |
| 113 | MP0002098_abnormal_vibrissa_morphology | 0.98989136 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.98857622 |
| 115 | MP0001697_abnormal_embryo_size | 0.97710293 |
| 116 | MP0003878_abnormal_ear_physiology | 0.97298757 |
| 117 | MP0005377_hearing/vestibular/ear_phenot | 0.97298757 |
| 118 | MP0001919_abnormal_reproductive_system | 0.96849989 |
| 119 | MP0009697_abnormal_copulation | 0.96825354 |
| 120 | MP0000689_abnormal_spleen_morphology | 0.95597991 |
| 121 | MP0002429_abnormal_blood_cell | 0.95576053 |
| 122 | MP0000427_abnormal_hair_cycle | 0.94820231 |
| 123 | MP0002111_abnormal_tail_morphology | 0.94471990 |
| 124 | MP0009379_abnormal_foot_pigmentation | 0.94229019 |
| 125 | MP0001119_abnormal_female_reproductive | 0.94120456 |
| 126 | MP0005367_renal/urinary_system_phenotyp | 0.93801264 |
| 127 | MP0000516_abnormal_urinary_system | 0.93801264 |
| 128 | MP0010030_abnormal_orbit_morphology | 0.93590282 |
| 129 | MP0005025_abnormal_response_to | 0.91848766 |
| 130 | MP0002234_abnormal_pharynx_morphology | 0.91597071 |
| 131 | MP0003938_abnormal_ear_development | 0.91443982 |
| 132 | MP0002405_respiratory_system_inflammati | 0.90053301 |
| 133 | MP0002166_altered_tumor_susceptibility | 0.89328710 |
| 134 | MP0009250_abnormal_appendicular_skeleto | 0.89018277 |
| 135 | MP0009333_abnormal_splenocyte_physiolog | 0.88863042 |
| 136 | MP0001286_abnormal_eye_development | 0.88704821 |
| 137 | MP0003786_premature_aging | 0.87486602 |
| 138 | MP0005395_other_phenotype | 0.87429275 |
| 139 | MP0000465_gastrointestinal_hemorrhage | 0.87256681 |
| 140 | MP0005397_hematopoietic_system_phenotyp | 0.86149912 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.86149912 |
| 142 | MP0005410_abnormal_fertilization | 0.86080339 |
| 143 | MP0005195_abnormal_posterior_eye | 0.86039447 |
| 144 | MP0002419_abnormal_innate_immunity | 0.85047308 |
| 145 | MP0002877_abnormal_melanocyte_morpholog | 0.84986280 |
| 146 | MP0000049_abnormal_middle_ear | 0.84890117 |
| 147 | MP0001968_abnormal_touch/_nociception | 0.84456865 |
| 148 | MP0003436_decreased_susceptibility_to | 0.82314015 |
| 149 | MP0001672_abnormal_embryogenesis/_devel | 0.81225098 |
| 150 | MP0005380_embryogenesis_phenotype | 0.81225098 |
| 151 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80179497 |
| 152 | MP0003950_abnormal_plasma_membrane | 0.76577725 |
| 153 | MP0009046_muscle_twitch | 0.76050553 |
| 154 | MP0002161_abnormal_fertility/fecundity | 0.75794377 |
| 155 | MP0003646_muscle_fatigue | 0.74384265 |
| 156 | MP0003122_maternal_imprinting | 0.74325050 |
| 157 | MP0004885_abnormal_endolymph | 0.73762996 |
| 158 | MP0002837_dystrophic_cardiac_calcinosis | 0.73578765 |
| 159 | MP0008872_abnormal_physiological_respon | 0.72278724 |
| 160 | MP0000778_abnormal_nervous_system | 0.71447212 |
| 161 | MP0000371_diluted_coat_color | 0.71185076 |
| 162 | MP0002282_abnormal_trachea_morphology | 0.69846713 |
| 163 | MP0001905_abnormal_dopamine_level | 0.69290798 |
| 164 | MP0005379_endocrine/exocrine_gland_phen | 0.69090256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.68425015 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.50045082 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.45424649 |
| 4 | Increased CSF lactate (HP:0002490) | 4.29818141 |
| 5 | Hepatocellular necrosis (HP:0001404) | 4.09803883 |
| 6 | Acute encephalopathy (HP:0006846) | 3.98914733 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.98706564 |
| 8 | Hepatic necrosis (HP:0002605) | 3.96456735 |
| 9 | Chromsome breakage (HP:0040012) | 3.55163508 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.36222374 |
| 11 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.27153484 |
| 12 | Increased serum lactate (HP:0002151) | 3.16374992 |
| 13 | Volvulus (HP:0002580) | 2.97737961 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 2.97494855 |
| 15 | Molar tooth sign on MRI (HP:0002419) | 2.90950932 |
| 16 | Abnormality of midbrain morphology (HP:0002418) | 2.90950932 |
| 17 | Birth length less than 3rd percentile (HP:0003561) | 2.82101701 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 2.81752212 |
| 19 | Asymmetry of the thorax (HP:0001555) | 2.76657986 |
| 20 | Hyperglycinemia (HP:0002154) | 2.75696455 |
| 21 | Cerebral edema (HP:0002181) | 2.73190462 |
| 22 | Cleft eyelid (HP:0000625) | 2.71491740 |
| 23 | Lactic acidosis (HP:0003128) | 2.70142082 |
| 24 | Colon cancer (HP:0003003) | 2.67176231 |
| 25 | Methylmalonic acidemia (HP:0002912) | 2.66901418 |
| 26 | Abnormal number of erythroid precursors (HP:0012131) | 2.66419018 |
| 27 | Methylmalonic aciduria (HP:0012120) | 2.65937813 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57939794 |
| 29 | Poor head control (HP:0002421) | 2.57115167 |
| 30 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.56294267 |
| 31 | Aplastic anemia (HP:0001915) | 2.56055667 |
| 32 | Lip pit (HP:0100267) | 2.56016863 |
| 33 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.55545181 |
| 34 | True hermaphroditism (HP:0010459) | 2.55215217 |
| 35 | Abnormality of the renal collecting system (HP:0004742) | 2.53850304 |
| 36 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.48339734 |
| 37 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.48339734 |
| 38 | Cupped ear (HP:0000378) | 2.44678884 |
| 39 | Abnormality of the anterior horn cell (HP:0006802) | 2.43876426 |
| 40 | Degeneration of anterior horn cells (HP:0002398) | 2.43876426 |
| 41 | Respiratory failure (HP:0002878) | 2.39822757 |
| 42 | Abnormality of chromosome stability (HP:0003220) | 2.39100002 |
| 43 | Congenital primary aphakia (HP:0007707) | 2.39023291 |
| 44 | Patellar aplasia (HP:0006443) | 2.38688146 |
| 45 | Exercise intolerance (HP:0003546) | 2.36853103 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.36588451 |
| 47 | Optic neuritis (HP:0100653) | 2.36588451 |
| 48 | Short tibia (HP:0005736) | 2.36299775 |
| 49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.35001901 |
| 50 | Reticulocytopenia (HP:0001896) | 2.32989569 |
| 51 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.32384972 |
| 52 | Hypoplasia of the fovea (HP:0007750) | 2.32384972 |
| 53 | Hypoplastic labia majora (HP:0000059) | 2.30009730 |
| 54 | Increased serum pyruvate (HP:0003542) | 2.28937977 |
| 55 | Gait imbalance (HP:0002141) | 2.28085289 |
| 56 | Abnormality of the preputium (HP:0100587) | 2.26733230 |
| 57 | Ectopic kidney (HP:0000086) | 2.26421294 |
| 58 | Medulloblastoma (HP:0002885) | 2.24808021 |
| 59 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.23252558 |
| 60 | Septo-optic dysplasia (HP:0100842) | 2.22328764 |
| 61 | Myelodysplasia (HP:0002863) | 2.20513980 |
| 62 | Thyroiditis (HP:0100646) | 2.19230784 |
| 63 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.18640328 |
| 64 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.18640328 |
| 65 | Abnormal protein glycosylation (HP:0012346) | 2.18640328 |
| 66 | Abnormal glycosylation (HP:0012345) | 2.18640328 |
| 67 | Abnormality of the fovea (HP:0000493) | 2.17821433 |
| 68 | Lymphoma (HP:0002665) | 2.16859298 |
| 69 | Meckel diverticulum (HP:0002245) | 2.15120915 |
| 70 | Absent eyebrow (HP:0002223) | 2.14636722 |
| 71 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.14516278 |
| 72 | Spinal cord lesions (HP:0100561) | 2.13569065 |
| 73 | Syringomyelia (HP:0003396) | 2.13569065 |
| 74 | Abnormal lung lobation (HP:0002101) | 2.12868612 |
| 75 | Neoplasm of the adrenal cortex (HP:0100641) | 2.12102109 |
| 76 | Acute myeloid leukemia (HP:0004808) | 2.12085092 |
| 77 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.11085710 |
| 78 | Respiratory difficulties (HP:0002880) | 2.10221879 |
| 79 | Abnormal hair whorl (HP:0010721) | 2.09929806 |
| 80 | Leukodystrophy (HP:0002415) | 2.09802527 |
| 81 | Optic disc pallor (HP:0000543) | 2.09742745 |
| 82 | Absent eyelashes (HP:0000561) | 2.09702582 |
| 83 | Intestinal atresia (HP:0011100) | 2.09661424 |
| 84 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.09586637 |
| 85 | Agnosia (HP:0010524) | 2.09009117 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 2.08766034 |
| 87 | Sclerocornea (HP:0000647) | 2.08197097 |
| 88 | Abnormality of the labia majora (HP:0012881) | 2.07205538 |
| 89 | Abnormality of glycolysis (HP:0004366) | 2.07159811 |
| 90 | Adrenal hypoplasia (HP:0000835) | 2.07053272 |
| 91 | Popliteal pterygium (HP:0009756) | 2.05602405 |
| 92 | Abnormality of cochlea (HP:0000375) | 2.05448185 |
| 93 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.05025344 |
| 94 | Short 4th metacarpal (HP:0010044) | 2.05025344 |
| 95 | Renal cortical cysts (HP:0000803) | 2.04072961 |
| 96 | Breast hypoplasia (HP:0003187) | 2.02041077 |
| 97 | Optic nerve coloboma (HP:0000588) | 2.00544429 |
| 98 | Abnormality of the ileum (HP:0001549) | 2.00374413 |
| 99 | Congenital stationary night blindness (HP:0007642) | 2.00163421 |
| 100 | CNS demyelination (HP:0007305) | 1.98825972 |
| 101 | Increased IgM level (HP:0003496) | 1.97880645 |
| 102 | Glycosuria (HP:0003076) | 1.97819036 |
| 103 | Abnormality of urine glucose concentration (HP:0011016) | 1.97819036 |
| 104 | Clubbing of toes (HP:0100760) | 1.96775011 |
| 105 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.96747851 |
| 106 | Stenosis of the external auditory canal (HP:0000402) | 1.94771585 |
| 107 | Anencephaly (HP:0002323) | 1.94062428 |
| 108 | Deep philtrum (HP:0002002) | 1.93183645 |
| 109 | Medial flaring of the eyebrow (HP:0010747) | 1.92947627 |
| 110 | Chronic otitis media (HP:0000389) | 1.92810448 |
| 111 | Facial cleft (HP:0002006) | 1.92230758 |
| 112 | Myositis (HP:0100614) | 1.91675953 |
| 113 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.91241379 |
| 114 | Absent thumb (HP:0009777) | 1.90024670 |
| 115 | 11 pairs of ribs (HP:0000878) | 1.88085310 |
| 116 | Ependymoma (HP:0002888) | 1.87571897 |
| 117 | Exertional dyspnea (HP:0002875) | 1.86430482 |
| 118 | Thrombocytosis (HP:0001894) | 1.85828407 |
| 119 | Amaurosis fugax (HP:0100576) | 1.85536007 |
| 120 | Granulocytopenia (HP:0001913) | 1.85026288 |
| 121 | Proximal placement of thumb (HP:0009623) | 1.84753463 |
| 122 | Deviation of the thumb (HP:0009603) | 1.82938969 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 1.82889413 |
| 124 | Embryonal renal neoplasm (HP:0011794) | 1.82836854 |
| 125 | Abnormality of the labia minora (HP:0012880) | 1.82454691 |
| 126 | Abnormality of renal resorption (HP:0011038) | 1.82333071 |
| 127 | Median cleft lip (HP:0000161) | 1.81693338 |
| 128 | Orchitis (HP:0100796) | 1.81683063 |
| 129 | Duodenal stenosis (HP:0100867) | 1.80411936 |
| 130 | Small intestinal stenosis (HP:0012848) | 1.80411936 |
| 131 | Macrocytic anemia (HP:0001972) | 1.80299686 |
| 132 | Atresia of the external auditory canal (HP:0000413) | 1.78566284 |
| 133 | Genital tract atresia (HP:0001827) | 1.78557905 |
| 134 | Preaxial hand polydactyly (HP:0001177) | 1.77612263 |
| 135 | Lethargy (HP:0001254) | 1.77147517 |
| 136 | IgM deficiency (HP:0002850) | 1.76341118 |
| 137 | Type I transferrin isoform profile (HP:0003642) | 1.76282103 |
| 138 | Eosinophilia (HP:0001880) | 1.76129893 |
| 139 | Tubulointerstitial nephritis (HP:0001970) | 1.75893793 |
| 140 | Recurrent viral infections (HP:0004429) | 1.75615354 |
| 141 | Abnormality of the renal cortex (HP:0011035) | 1.75409250 |
| 142 | Generalized aminoaciduria (HP:0002909) | 1.74468763 |
| 143 | Duplicated collecting system (HP:0000081) | 1.73744251 |
| 144 | Leukocytosis (HP:0001974) | 1.73235266 |
| 145 | Nephrogenic diabetes insipidus (HP:0009806) | 1.72648810 |
| 146 | Abnormality of eosinophils (HP:0001879) | 1.72575937 |
| 147 | Retinal dysplasia (HP:0007973) | 1.72386851 |
| 148 | Pancreatic cysts (HP:0001737) | 1.72031165 |
| 149 | Rhabdomyosarcoma (HP:0002859) | 1.72008951 |
| 150 | White forelock (HP:0002211) | 1.71738301 |
| 151 | Vaginal atresia (HP:0000148) | 1.71630413 |
| 152 | Sloping forehead (HP:0000340) | 1.71341451 |
| 153 | Increased muscle lipid content (HP:0009058) | 1.71117327 |
| 154 | Premature graying of hair (HP:0002216) | 1.70958033 |
| 155 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.70398017 |
| 156 | Impulsivity (HP:0100710) | 1.69707638 |
| 157 | Abnormality of the duodenum (HP:0002246) | 1.69092475 |
| 158 | Neoplasm of the adrenal gland (HP:0100631) | 1.68820118 |
| 159 | Abnormal number of incisors (HP:0011064) | 1.68189366 |
| 160 | Cystic liver disease (HP:0006706) | 1.67933352 |
| 161 | Abnormality of the parietal bone (HP:0002696) | 1.67758076 |
| 162 | Papillary thyroid carcinoma (HP:0002895) | 1.66906057 |
| 163 | X-linked dominant inheritance (HP:0001423) | 1.66879888 |
| 164 | Pancreatic fibrosis (HP:0100732) | 1.66829242 |
| 165 | Trigonocephaly (HP:0000243) | 1.64560560 |
| 166 | Morphological abnormality of the inner ear (HP:0011390) | 1.64318378 |
| 167 | Increased nuchal translucency (HP:0010880) | 1.63426210 |
| 168 | Absent radius (HP:0003974) | 1.63192349 |
| 169 | Stomach cancer (HP:0012126) | 1.62807869 |
| 170 | Cortical dysplasia (HP:0002539) | 1.60945142 |
| 171 | Short middle phalanx of the 5th finger (HP:0004220) | 1.60104861 |
| 172 | Recurrent abscess formation (HP:0002722) | 1.59609363 |
| 173 | Supernumerary spleens (HP:0009799) | 1.59408900 |
| 174 | Combined immunodeficiency (HP:0005387) | 1.59047888 |
| 175 | Anal stenosis (HP:0002025) | 1.57794052 |
| 176 | Abnormality of the intervertebral disk (HP:0005108) | 1.57779289 |
| 177 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.57401336 |
| 178 | Cutaneous melanoma (HP:0012056) | 1.56793798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.84307118 |
| 2 | TRIM28 | 3.28171662 |
| 3 | CDC7 | 3.18640305 |
| 4 | MKNK1 | 3.08630513 |
| 5 | PLK4 | 2.77776635 |
| 6 | BUB1 | 2.67670663 |
| 7 | SRPK1 | 2.66094716 |
| 8 | VRK1 | 2.65100779 |
| 9 | WNK3 | 2.49687507 |
| 10 | WEE1 | 2.39745620 |
| 11 | MKNK2 | 2.37669704 |
| 12 | EIF2AK1 | 2.11460465 |
| 13 | ZAK | 2.09510649 |
| 14 | BRSK2 | 2.08945909 |
| 15 | PASK | 2.05480539 |
| 16 | PLK3 | 2.02806653 |
| 17 | TSSK6 | 2.02306746 |
| 18 | EIF2AK3 | 1.94776516 |
| 19 | STK10 | 1.94452253 |
| 20 | ACVR1B | 1.90010128 |
| 21 | IRAK4 | 1.89242462 |
| 22 | MAP3K3 | 1.83027811 |
| 23 | TLK1 | 1.83006876 |
| 24 | TTK | 1.80472503 |
| 25 | EIF2AK2 | 1.74920437 |
| 26 | GRK1 | 1.70568253 |
| 27 | YES1 | 1.67187888 |
| 28 | ATR | 1.64706982 |
| 29 | FRK | 1.62968914 |
| 30 | PBK | 1.55747570 |
| 31 | MAP3K2 | 1.50933272 |
| 32 | ERBB3 | 1.49907122 |
| 33 | NEK2 | 1.46121206 |
| 34 | LIMK1 | 1.45353168 |
| 35 | MAP4K2 | 1.44049291 |
| 36 | PLK1 | 1.41028225 |
| 37 | CDK19 | 1.36953226 |
| 38 | STK4 | 1.31714289 |
| 39 | CDK7 | 1.30455233 |
| 40 | AURKB | 1.28727486 |
| 41 | MAP3K4 | 1.26859309 |
| 42 | ADRBK2 | 1.26787616 |
| 43 | MAP3K14 | 1.25722651 |
| 44 | MAP2K7 | 1.23789343 |
| 45 | NEK1 | 1.22102106 |
| 46 | TXK | 1.20158029 |
| 47 | BRD4 | 1.18493389 |
| 48 | CHEK2 | 1.17078275 |
| 49 | JAK3 | 1.16701949 |
| 50 | TEC | 1.13095725 |
| 51 | BCKDK | 1.09404625 |
| 52 | NEK6 | 1.09274966 |
| 53 | MAPK13 | 1.08985124 |
| 54 | BRSK1 | 1.05805786 |
| 55 | STK16 | 1.05641013 |
| 56 | RPS6KB2 | 1.03838186 |
| 57 | EPHA4 | 1.02227896 |
| 58 | TGFBR1 | 1.00536598 |
| 59 | PDK2 | 1.00503311 |
| 60 | NLK | 0.99420211 |
| 61 | CSNK1G1 | 0.98792369 |
| 62 | EEF2K | 0.98228588 |
| 63 | CHEK1 | 0.96511656 |
| 64 | MAP3K8 | 0.95302538 |
| 65 | STK38L | 0.93514122 |
| 66 | CSNK1G3 | 0.92274516 |
| 67 | MST4 | 0.91961576 |
| 68 | MAP3K12 | 0.91472491 |
| 69 | ATM | 0.91361742 |
| 70 | OXSR1 | 0.91317854 |
| 71 | NUAK1 | 0.91273139 |
| 72 | TYK2 | 0.90909195 |
| 73 | PIM1 | 0.87683569 |
| 74 | CASK | 0.87247963 |
| 75 | KIT | 0.87111871 |
| 76 | PIM2 | 0.87108127 |
| 77 | NME1 | 0.85656874 |
| 78 | MAP4K1 | 0.85311739 |
| 79 | PAK3 | 0.85078599 |
| 80 | TAOK3 | 0.84366313 |
| 81 | CCNB1 | 0.83886998 |
| 82 | CDK8 | 0.83775079 |
| 83 | STK3 | 0.83355220 |
| 84 | RPS6KA4 | 0.82538540 |
| 85 | MAP3K9 | 0.81724517 |
| 86 | CHUK | 0.81475162 |
| 87 | DYRK2 | 0.80224087 |
| 88 | ARAF | 0.79886208 |
| 89 | STK39 | 0.79710023 |
| 90 | AURKA | 0.79288538 |
| 91 | DYRK3 | 0.77768591 |
| 92 | MELK | 0.74875988 |
| 93 | PINK1 | 0.74341450 |
| 94 | IRAK3 | 0.71937492 |
| 95 | PLK2 | 0.70554899 |
| 96 | BMPR2 | 0.69898039 |
| 97 | CSNK1G2 | 0.69780530 |
| 98 | BRAF | 0.68616526 |
| 99 | BTK | 0.68582466 |
| 100 | CDK12 | 0.67906453 |
| 101 | NEK9 | 0.66720816 |
| 102 | WNK4 | 0.66427160 |
| 103 | SIK3 | 0.64938896 |
| 104 | IKBKB | 0.64648079 |
| 105 | PRKCE | 0.64552463 |
| 106 | TESK1 | 0.63603857 |
| 107 | BLK | 0.62564588 |
| 108 | CSNK2A2 | 0.62038102 |
| 109 | EPHA3 | 0.61766203 |
| 110 | RPS6KA5 | 0.61517666 |
| 111 | GRK5 | 0.60979205 |
| 112 | MARK3 | 0.60661706 |
| 113 | TESK2 | 0.59326311 |
| 114 | MAPKAPK2 | 0.58647784 |
| 115 | IKBKE | 0.58586375 |
| 116 | SYK | 0.58183052 |
| 117 | CDK4 | 0.57935931 |
| 118 | TNIK | 0.57253002 |
| 119 | BMPR1B | 0.56538414 |
| 120 | CDK2 | 0.54809330 |
| 121 | PRKCG | 0.51197833 |
| 122 | PRKCI | 0.50873576 |
| 123 | CDK1 | 0.50312737 |
| 124 | HIPK2 | 0.50272969 |
| 125 | RPS6KB1 | 0.49330335 |
| 126 | FLT3 | 0.48166894 |
| 127 | CSF1R | 0.47751866 |
| 128 | LYN | 0.47312129 |
| 129 | CSNK2A1 | 0.46305265 |
| 130 | MINK1 | 0.46005985 |
| 131 | CDK6 | 0.45806214 |
| 132 | BCR | 0.44826589 |
| 133 | TAF1 | 0.42967344 |
| 134 | CLK1 | 0.42750283 |
| 135 | LRRK2 | 0.42172509 |
| 136 | GRK7 | 0.41093737 |
| 137 | LCK | 0.39325384 |
| 138 | CSNK1A1L | 0.38802708 |
| 139 | SIK2 | 0.37765425 |
| 140 | NME2 | 0.37430046 |
| 141 | RAF1 | 0.37008815 |
| 142 | CSNK1A1 | 0.36121266 |
| 143 | PAK1 | 0.35892695 |
| 144 | DAPK1 | 0.33626071 |
| 145 | KSR1 | 0.33535505 |
| 146 | ADRBK1 | 0.31663499 |
| 147 | CAMK2D | 0.31195242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.55130855 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.50756223 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.30518418 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.00023023 |
| 5 | Cell cycle_Homo sapiens_hsa04110 | 2.80153368 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.73128251 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.44152825 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.36980519 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.34569842 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.30742537 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.29003293 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.25043069 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.22393902 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.19163345 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 2.11652600 |
| 16 | RNA degradation_Homo sapiens_hsa03018 | 2.10750506 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 2.08193404 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.07823922 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.03599196 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 2.02362535 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 2.01455444 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.00904806 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76453094 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.76296736 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.73662476 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70629222 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.67404958 |
| 28 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.63460696 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.62943526 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60072372 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.58831312 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.58528897 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55926660 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.52799364 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47514142 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.42832653 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.41814495 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41765809 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.40315760 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.40111933 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39397684 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38124542 |
| 43 | Measles_Homo sapiens_hsa05162 | 1.37284116 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32341889 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30981071 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.30887793 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30441467 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29177115 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.27774854 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26429660 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23662769 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23238604 |
| 53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21871249 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16340334 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13448198 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12939690 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12790398 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 1.12304673 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 1.10547611 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10331496 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09078703 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06902716 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04689208 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04550176 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04017350 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99985125 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98980941 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98780914 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98765483 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.98098213 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96749845 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96317425 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93865934 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92844456 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.88894045 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.88406113 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88378612 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.86629035 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82438484 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82140091 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81982388 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81232710 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.80975957 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80696089 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79762183 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77328556 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.75576109 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.75170446 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.69937913 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.69916944 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68691565 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68255756 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67823763 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67314177 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.67304737 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65854833 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65198564 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64502302 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.64405442 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63155001 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60850030 |
| 102 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60078052 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59893840 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59747194 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59589306 |
| 106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59289073 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58950976 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58352437 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57794931 |
| 110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57765723 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57761769 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54917841 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54253896 |
| 114 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50441018 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48760869 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48081859 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.47726115 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47480692 |
| 119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47320958 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46652574 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44570670 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44546038 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42648161 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42342374 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42156287 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.41761580 |
| 127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41340781 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41201880 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40234716 |
| 130 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39292220 |
| 131 | Hepatitis C_Homo sapiens_hsa05160 | 0.39267264 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.39221127 |
| 133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38854850 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38163917 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37849585 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37526640 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37001875 |
| 138 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36733415 |
| 139 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36246666 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35230372 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.35183723 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35000345 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34956635 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34634170 |
| 145 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.33832246 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33087312 |
| 147 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33058442 |
| 148 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32831056 |
| 149 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32607282 |
| 150 | Tuberculosis_Homo sapiens_hsa05152 | 0.32550794 |
| 151 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31543785 |
| 152 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31300024 |
| 153 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31211942 |
| 154 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29205397 |
| 155 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27780441 |
| 156 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.18488295 |
| 157 | Olfactory transduction_Homo sapiens_hsa04740 | 0.16771039 |
| 158 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.16667431 |
| 159 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.14114783 |
| 160 | Taste transduction_Homo sapiens_hsa04742 | 0.12121966 |
| 161 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11826626 |
| 162 | Nicotine addiction_Homo sapiens_hsa05033 | 0.11416448 |
| 163 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.10646458 |
| 164 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.10454887 |

